{"paper_id":"bf6ee65e-d388-4535-abac-c14091a50332","body_text":"Abstract\nBackground:\nEndometriosis is associated with heterogeneous symptoms and frequently involves a prolonged route from symptom onset to diagnosis. The term diagnostic delay is used for different intervals, however, and studies vary in their populations, diagnostic endpoints and healthcare settings. In Germany, evidence is distributed across specialist-centre studies, qualitative research, health-services and clinical guidelines.\nObjective:\nTo critically synthesise the available Germany-relevant evidence on diagnostic delay and the diagnostic pathway of endometriosis, with particular attention to the distinction between patient, provider and system processes, the interpretation of administrative data, and priorities for German health-services research.\nReview approach:\nA focused, non-systematic search and source-identification approach was used. The literature was identified through focused searches of PubMed, publicly accessible publisher and registry pages, German health-services sources including the Versorgungsatlas, national and international guidelines, and backward and forward citation searching. German primary studies were prioritised; international reviews and selected European guidance were used for conceptual context. Sources were selected for direct relevance to diagnostic intervals, healthcare contacts, referrals, diagnostic attribution, access or patient experience. No complete multi-database export, duplicate screening or formal systematic-review workflow was undertaken.\nSynthesis:\nGerman evidence indicates that the pathway to diagnosis can extend over several years, but the reported estimates are not directly interchangeable. A mixed Austria–Germany tertiary-centre study reported a median symptom-to-diagnosis interval of 10.4 years, while a German EndoCost analysis reported a mean total interval of 7.0 years, with mean patient and physician intervals of 2.8 and 4.2 years, respectively. A qualitative German study describes the importance of being heard, symptom recognition and communication in healthcare encounters. Nationwide claims and Versorgungsatlas analyses describe documented diagnosis patterns and regional variation, but cannot measure symptom onset or the unrecorded period before diagnosis.\nConclusions:\nThe available evidence supports understanding diagnostic delay as a cumulative, cross-sector pathway problem rather than as one nationally representative number or one isolated clinical failure. Germany needs standardised interval definitions, prospective longitudinal data, linkage of patient-reported information with routine-care trajectories, and implementation research on referral and specialist access. The conclusions are limited by the non-systematic search and by the selection and measurement limitations of the underlying studies.\n1 Introduction\nEndometriosis is a chronic, clinically heterogeneous condition associated with symptoms that may include dysmenorrhoea, chronic pelvic pain, dyspareunia, bowel or bladder complaints and infertility. Symptoms may be intermittent, cycle-related or attributed to other disorders. The resulting diagnostic challenge is not only a matter of identifying a disease label; it also concerns whether symptoms are recognised, investigated and connected across successive healthcare encounters (\n, ).A prolonged diagnostic pathway may include delayed help-seeking, repeated consultations, symptom-oriented treatment, alternative diagnostic attributions, referrals between specialties, imaging, emergency care and, in some patients, operative or histological confirmation. During this pathway, access to effective symptom management, fertility counselling, information and specialised multidisciplinary care may also be delayed. Diagnostic delay should therefore be considered a clinical, patient-experience and health-services issue (\n– ).The central methodological problem is that diagnostic delay is not a single uniform construct. Studies may measure the period from symptom onset to diagnosis, the period from first healthcare contact to clinical recognition, the time between referral and specialist assessment, or the interval between symptom-related and endometriosis-specific administrative codes. These measures answer different questions. They are also influenced by the diagnostic endpoint: clinical diagnosis, imaging-supported diagnosis, operative diagnosis, histological confirmation and claims-based coding should not be treated as equivalent (\n).For the interpretive framework used in this review, three components are distinguished when a study provides the relevant measurement points (\nTable 1) (\n):\nPatient interval: from the onset or recognition of relevant symptoms to the first professional healthcare contact.\nProvider or clinical interval: from the first professional contact to clinical recognition, targeted investigation or a documented suspicion of endometriosis.\nSystem interval: from suspicion, referral or initial investigation to specialist assessment, diagnostic confirmation or access to appropriate care.\nTable 1\n| Interval or endpoint | What it measures | What it cannot establish on its own |\n|---|---|---|\n| Symptom-to-diagnosis interval | Time from defined symptom onset to a stated diagnostic endpoint | Which stage caused the interval or whether recall is accurate |\n| Patient interval | Time from symptom onset or recognition to first professional contact | Whether access, knowledge, symptoms or competing demands explain the timing |\n| Provider or clinical interval | Time from first contact to suspicion or targeted diagnostic work-up | Individual clinician causality or the influence of referral constraints |\n| System or referral interval | Time from suspicion or referral to specialist assessment or confirmation | The full pre-referral symptom history |\n| Claims-documented interval | Time between coded healthcare events | Unrecorded symptoms, uncoded care, clinical reasoning or true disease onset |\nDefinitions that should remain separate.\nThese components are conceptual rather than universally standardised. They cannot be added together unless the study defines compatible starting points and endpoints. Their value lies in directing attention to different mechanisms and potential points of intervention.\nGermany offers an important setting for examining this pathway. Care is distributed across primary care, office-based gynaecology and other specialties, hospitals and specialised endometriosis centres (\n). Routine data can describe documented diagnoses and healthcare utilisation, but they generally do not record the onset of symptoms or the period during which a person has not yet sought care. Patient questionnaires and qualitative interviews capture experiences and retrospective intervals, but may be affected by recall, selection and referral-centre bias. No single source therefore provides a complete account of the diagnostic journey ( , – ).This review addressed the following four research questions:\nWhich diagnostic intervals have been reported in German studies, and how were their starting and end points defined?\nWhich healthcare settings, specialties, referral processes and diagnostic procedures are described along the diagnostic pathway?\nWhich patient-, provider- and system-level factors are reported as being associated with, or perceived to contribute to, longer diagnostic pathways?\nWhich methodological and substantive evidence gaps are most relevant to the design of future German longitudinal or mixed-methods health-services research?\nThe review did not aim to calculate a new national estimate of diagnostic delay. Instead, it synthesised complementary evidence, considered the strengths and limitations of different source types, and identified priorities for future health-services research. International reviews and selected European guidance were used to clarify concepts and contextualise the German evidence, but not to establish a country ranking.\nThe purpose of this review is not to calculate a new national estimate. It is to bring together complementary evidence, identify what each source can and cannot show, and develop a clinically and methodologically cautious interpretation of the German diagnostic pathway. Accordingly, the review asks which diagnostic intervals have been reported and how they were defined; which healthcare contacts, specialties, referrals and diagnostic procedures are described; which patient-, provider- and system-level mechanisms recur across evidence types; and which methodological and substantive gaps should guide future German health-services research. International reviews and selected European guidance are used only to clarify concepts and contextualise the German evidence. They are not used to create a country ranking.\n2 Review approach\n2.1 Design and epistemic position\nA critical narrative review was selected because the relevant evidence is heterogeneous in design, measurement and purpose. The sources include retrospective questionnaire studies, qualitative interviews, claims analyses, health-services reports, protocols, systematic reviews and clinical guidance. The review is therefore interpretive and integrative rather than exhaustive and aggregative.\nThe review does not use the terminology of a completed systematic or scoping review. In particular, it does not claim that all records from Embase, Web of Science, Scopus, CINAHL, PsycINFO or the Cochrane Library were retrieved, exported, deduplicated and screened. The absence of that claim is a methodological boundary, not an assertion that those databases are unnecessary for a future systematic review.\nA large language model (LLM) was used to support idea generation, formulation, and manuscript structuring; all content, references, interpretations, and the final text were critically reviewed and approved by the author.\n2.2 Identification of literature and public sources\nThe source-identification process (\nFigure 1) used combinations of the following concepts:\nendometriosis;\ndiagnostic delay, time to diagnosis, diagnostic interval or diagnostic pathway;\nhealthcare, primary care, gynaecology, referral, misdiagnosis, barriers, access, specialist care or patient experience;\nGermany, German or Deutschland for the primary national focus.\nFigure 1\nThe focused search used PubMed-oriented searches and examination of publicly accessible publisher, indexing, registry and full-text pages. Additional sources were identified from the AWMF guideline register, ESHRE and NICE guidance, the German Versorgungsatlas, relevant German health-services organisations, and backward and forward citation searching of key studies and reviews. Searches and source verification were updated during manuscript development through 4 September 2026.\nA representative search structure was:\nThis string describes the conceptual approach rather than a validated, database-specific search strategy. Search syntax, indexing terms and geographic filters were not identical across sources. Country terms were treated as supplementary terms because a German study may report its setting only in the abstract, full text or institutional information.\n2.3 Source selection, synthesis and transparency\nSources were included in the narrative when they made a direct or clearly relevant contribution to at least one of the review questions. German empirical studies were prioritised for the core synthesis. German routine-data reports and protocols were used to describe the health-services context and research infrastructure. International systematic or scoping reviews were used to clarify the wider evidence on diagnostic delay and to identify recurring conceptual issues. Guidelines were treated as normative sources: they describe recommended care, not necessarily care as delivered.\nThe sources were compared with respect to population and setting, recruitment or observation period, data source, degree of retrospective reporting, definition of symptom onset, diagnostic endpoint, healthcare level, specialties represented, type of evidence and relevance to Germany. Particular attention was paid to selection, recall, coding and measurement bias, as well as to the transferability of findings from specialist-centre populations or other healthcare systems. Reported means and medians were kept separate. Specialist-centre studies were not treated as population-representative, claims-based diagnosis was not treated as direct measurement of symptom-to-diagnosis time, and qualitative findings were synthesised as themes rather than converted into prevalence estimates. Associations were not interpreted as causal effects.\nFor each included source, we extracted information on study design, healthcare setting, sample size, age range, inclusion criteria, diagnostic ascertainment and the reporting or analysis of potentially relevant population characteristics, including migration background, socioeconomic status, insurance status and transition from paediatric to adult care. If a characteristic was not mentioned in the source, it was recorded as “not reported” and was not interpreted as evidence that the characteristic had not been assessed.\nNo formal patient and public involvement process was conducted for this review. The review used published or publicly accessible material and did not collect individual-level participant data; no new ethics approval was therefore sought for the review itself. The absence of patient involvement is a limitation, particularly for an article that interprets patient experience. Future work should involve patient organisations in defining outcomes, interpreting pathway barriers and assessing the acceptability of proposed improvements.\nBecause the search was focused and non-systematic, the review is vulnerable to selection bias, publication bias and incomplete retrieval. These limitations are treated as part of the findings rather than concealed by systematic-review terminology.\n3 German evidence on the diagnostic pathway\n3.1 Evidence types and reported diagnostic intervals\nThe Germany-relevant evidence (Table 2) is small, diverse and distributed across different levels of the health system. It includes a mixed Austria–Germany tertiary-centre questionnaire study, a German secondary analysis of EndoCost data, a qualitative German interview study, nationwide ambulatory claims analyses, a Versorgungsatlas report, a German mixed-methods protocol on rural care, and clinical guidelines. These sources do not constitute one coherent dataset. They should be read as partial views of a pathway: specialist-centre studies provide detailed retrospective patient information; qualitative research provides meaning and interactional context; and routine data describe documented care at scale.\nTable 2\n| Source | Evidence type | Main contribution | Important limitation |\n|---|---|---|---|\n| Hudelist et al. ( | )Retrospective multicentre questionnaire; Austria and Germany | Symptom-to-diagnosis interval and previous diagnostic attributions in tertiary-centre patients | Countries not separated; specialist-centre selection; recall bias |\n| Brandes et al. ( | )Cross-sectional secondary analysis of German EndoCost data | Separates total, patient and physician intervals | Retrospective and centre-based; not population representative |\n| Brauer et al. ( | )Qualitative patient interviews in Germany | Experience of recognition, communication and being taken seriously | Qualitative sample cannot estimate prevalence or average delay |\n| Kohring et al. ( | )Nationwide ambulatory claims analysis | Documented diagnosis and temporal patterns at scale | No direct observation of symptom onset or clinical reasoning |\n| Kohring et al. ( | )Versorgungsatlas regional and temporal report | Regional variation in documented outpatient diagnosis | Variation is not equivalent to variation in diagnostic delay |\n| Brauer and Geraedts ( | )Mixed-methods study protocol | Illustrates the need to study rural access and quality of care | Protocol; no empirical results |\n| AWMF, ESHRE and NICE ( | )Clinical guidance | Normative expectations for diagnosis, referral and care | Recommendations do not measure implementation |\nGermany-relevant evidence and its interpretive contribution.\nHudelist and colleagues conducted a multicentre questionnaire study in tertiary referral centres in Austria and Germany among patients with histologically confirmed endometriosis. The study reported a median interval of 10.4 years from symptom onset to diagnosis and frequent previous diagnostic attributions, including a previous misdiagnosis in 74% of participants as reported by the authors (\n). This is an important Germany-relevant signal, but it is not a Germany-only population estimate. The participating centres were specialist referral settings, the study combined two countries, and the interval was reconstructed retrospectively.Brandes and colleagues analysed German participants from the EndoCost study. In the principal analytic sample, the reported mean total interval was 7.0 years and the median was 5.0 years. The analysis also separated a mean patient interval of 2.8 years from a mean physician interval of 4.2 years (\n). This decomposition is valuable because it demonstrates that the time before and after first physician contact can be examined separately. It does not, however, establish that physician-level factors alone caused the longer component. The study was cross-sectional, retrospective and based on participants recruited through specialist centres.The estimates from Hudelist et al. and Brandes et al. should therefore not be averaged. They differ in country composition, recruitment setting, sample, calendar period, operational definitions and statistical summaries. Their combined contribution is not a single national number; it is evidence that long pathways are observed in Germany-relevant specialist populations and that the pathway can contain more than one measurable interval.\n3.2 Patient experience, care encounters and the possible implementation gap\nThe qualitative study by Brauer, de Cruppé and Geraedts examined the healthcare experiences of women with endometriosis in Germany (\n). Its contribution is not an estimate of diagnostic delay but an account of how the pathway is experienced in encounters with healthcare professionals. The reported focus on being taken seriously, recognition of symptoms, communication and supportive or obstructive interactions complements the quantitative interval studies.This perspective matters methodologically. A consultation can accelerate the pathway when symptoms are recognised, questions are pursued and referral is facilitated. Conversely, the same formal healthcare contact may not advance diagnosis if symptoms are normalised, attributed to another condition without adequate reassessment, or managed without a clear plan for review. These observations should not be converted into a claim that individual clinicians are the sole cause of delay. They point instead to interactions between clinical knowledge, communication, time, referral arrangements and patient trust. The qualitative evidence also cautions against a purely chronological definition of the problem: patients may experience the pathway as a sequence of invalidation, uncertainty and repeated decisions, not simply as a number of elapsed years.\nThe German S2k guideline on the diagnosis and treatment of endometriosis, including the current AWMF register entry, provides a normative framework for clinical assessment and management (\n). The ESHRE guideline and the NICE guideline offer additional European reference points for diagnosis, referral and organisation of care ( , ). These documents help define what timely and appropriate care is intended to involve, but they cannot demonstrate that the recommended pathway is implemented consistently. Recommendations for symptom assessment, diagnostic evaluation and referral do not show how often they are followed in primary care, gynaecology, emergency care or rural settings. The implementation gap is therefore an empirical question.3.3 Claims data, documented diagnoses and regional variation\nKohring and colleagues analysed nationwide ambulatory claims data from physicians in private practice for the period 2014–2022 to describe the incidence of diagnosed endometriosis (\n). The study is valuable for examining documented disease patterns at scale, but claims data do not directly observe symptom onset, unrecorded help-seeking or the clinical reasoning that preceded a code. A first recorded diagnosis is therefore an epidemiological or utilisation endpoint, not automatically the end of the true patient interval.A related Versorgungsatlas analysis examined regional and temporal patterns in outpatient care from 2012 to 2022 (\n). The crude documented diagnosis prevalence among girls and women aged 10 years and older increased from 5.7 per 1,000 in 2012 to 9.5 per 1,000 in 2022, a relative increase of 65%. In 2022, 339,718 insured girls and women in the analysed population had a documented endometriosis diagnosis. The report also described regional variation, including a 1.7-fold difference between regions of the statutory ambulatory-care system and a larger variation at district level ( ).These findings are relevant to health-services research but require careful interpretation. An increase in documented diagnoses may reflect changes in disease recognition, coding, healthcare utilisation, access, referral patterns, population composition or a combination of these factors. Regional variation may indicate differences in care, but it may also reflect diagnostic activity, specialist availability, coding practice and case ascertainment. Claims data cannot, on their own, establish that one region has a shorter or longer symptom-to-diagnosis interval than another.\nA further interpretive caution concerns the diagnostic endpoint itself. Over the observation period covered by these analyses, guideline recommendations moved away from diagnostic laparoscopy as a prerequisite for diagnosis and towards clinical and imaging-based diagnosis (\n, ). The operational meaning of a documented diagnosis may therefore have changed during the same period in which documented prevalence increased. Time-trend analyses that treat a coded diagnosis as a constant endpoint may consequently confound a genuine change in recognition with a shift in the criteria that generate the code. Reports of temporal trends should state which diagnostic definition applied in each period and, where the data permit, examine whether the proportion of surgically confirmed diagnoses changed over time.The German mixed-methods protocol focused on rural Hesse further illustrates the need to study regional access and quality of care with methods that combine utilisation data and patient or professional perspectives (\n). As a protocol, it is evidence of a research priority rather than evidence of an observed regional effect.3.4 International context and economic relevance\nInternational syntheses reinforce the central measurement problem. De Corte and colleagues identified 17 studies reporting time to diagnosis and found substantial variation in definitions, designs and reported estimates; mean and median times ranged from 0.3 to 12 years across the included studies (\n). Li and colleagues similarly concluded that diagnostic delay remains substantial and involves patient-, provider- and system-level factors, while emphasising variation across studies ( ). A separate scoping review using a social-ecological framework reported an average delay of 6.8 years across studies, with a wide range between settings ( ).These reviews support the interpretation that diagnostic delay is persistent and multi-level, but they do not solve the problem of estimating a German national interval. Their value for the present review is conceptual: they provide a framework for avoiding patient-blaming explanations and for separating different stages of the pathway.\nDelayed diagnosis may be accompanied by prolonged symptoms, repeated healthcare contacts, delayed treatment and impaired participation in work or everyday life. A US-based retrospective analysis found that patients with longer diagnostic delays had higher pre-diagnosis healthcare utilisation and costs (\n). These findings make the issue relevant to health economics, but they should not be presented as a Germany-specific causal estimate. German cost estimates require a separate analysis with clearly defined populations, time horizons, resource categories and costing methods. The EndoCost programme provides a relevant foundation for that type of work, but a protocol or study-derived estimate should not be treated as a current national burden estimate ( ).The economic burden of endometriosis extends beyond reimbursed healthcare expenditure and includes substantial costs borne by patients, employers and society. In a multinational European study, productivity losses accounted for approximately two thirds of the total annual economic burden, exceeding direct healthcare costs. Recent population based data further indicate reduced work participation, increased sickness absence and impaired productivity among women with endometriosis. In Germany, patients also report considerable self-funded expenses and indirect costs related to the disease, averaging more than €4,000 annually in one survey. These findings indicate that health economic evaluations should incorporate patient expenditure, employment consequences and productivity losses alongside direct healthcare costs.\n4 Critical synthesis: diagnostic delay as a cumulative pathway problem\n4.1 Measurement, triangulation and the limits of a national estimate\nThe available studies show why a single German average would be methodologically fragile. The start point may be first symptom, first remembered symptom, first severe symptom or first healthcare contact. The endpoint may be clinical suspicion, imaging, surgery, histology or an administrative code. Samples may be recruited from specialist centres, patient communities or routine-care databases, and means and medians may describe different distributions. These differences can alter the reported interval even when the underlying patient experience is similar.\nEach evidence type contributes a different view of the pathway. Patient questionnaires can estimate retrospective intervals and identify previous diagnostic attributions, but are vulnerable to recall and referral-centre bias. Qualitative interviews can explain how recognition, communication and trust shape the pathway, but do not estimate population prevalence or average delay. Claims data can describe documented diagnoses, healthcare utilisation and regional patterns, but cannot directly observe symptom onset, unrecorded care or the reasons behind clinical decisions. Guidelines define recommended diagnostic and referral practice, but do not measure implementation. International reviews help organise recurring mechanisms and definitions, but their estimates cannot be transferred uncritically to Germany.\nThe strength of a Germany-centred synthesis therefore lies in triangulation, not numerical aggregation. The most defensible conclusion is not that German patients experience exactly a particular number of years of delay. It is that long diagnostic pathways are documented in Germany-relevant specialist studies, that multiple components of the pathway can be distinguished, and that the current evidence does not support a nationally representative interval.\n4.2 A multi-level pathway model and research gaps\nThe German evidence is consistent with a cumulative model:\nBased on the reviewed evidence, we propose a multi-level conceptual synthesis (Figure 2). At the patient level, symptom interpretation, normalisation, uncertainty and competing demands may influence when care is sought ( ). At the provider level, recognition of varied symptom presentations, differential diagnosis, communication and follow-up matter ( ). At the system level, referral pathways, waiting times, regional specialist availability, sectoral boundaries and access to expertise may shape what happens after help-seeking ( – ). These levels interact. A patient-level factor should not be used to absolve deficiencies in care, and a provider-level association should not be interpreted as proof of individual causality.\nFigure 2\nThis figure is a conceptual synthesis of the reviewed evidence and should not be interpreted as a universal sequence or as a causal model validated in a German cohort (Figure 3).\nFigure 3\nRegional access is a plausible component of the German pathway, but the available evidence does not yet permit a robust causal interpretation of regional variation in diagnostic delay. Claims-based regional differences document variation in diagnosis, not necessarily variation in the time from symptoms to diagnosis. The rural Hesse research programme is relevant because it points toward a mixed-methods approach that can connect utilisation with experiences of access (\n).Participant characteristics and the assessment of potentially relevant subgroups varied across the included studies. Information on age and clinical setting was reported more consistently than information on migration background, socioeconomic status, insurance status or the transition from paediatric to adult care. These characteristics were not consistently defined, measured or analysed across the available evidence. Consequently, the absence of reported differences should not be interpreted as evidence that no differences exist. The available literature is therefore insufficient to draw robust conclusions regarding diagnostic pathways in adolescents, people with a migration background, different socioeconomic or insurance groups, or those transitioning from paediatric to adult care. A detailed overview of the study populations and the reporting of these characteristics is provided in Table 3.\nTable 3\n| Source | Design, setting and population | Characteristics not reported or not directly examined |\n|---|---|---|\n| Hudelist et al. ( | )Retrospective, cross-sectional questionnaire study in tertiary referral centres in Austria and Germany; n = 171 patients | Migration background, socioeconomic status, insurance status and transition from paediatric to adult care were not reported; Austrian and German participants were not analysed separately |\n| Brandes et al. ( | )Cross-sectional secondary analysis of German EndoCost data from three specialist centres; 157 questionnaires completed, 130 participants included in the analytic sample | Migration background, insurance status and transition from paediatric to adult care were not reported |\n| Brauer et al. ( | )Qualitative, semi-structured interview study in Central and Eastern Hesse, Germany; purposive heterogeneous sample of 21 women | Migration background, insurance status and transition from paediatric to adult care were not reported |\n| Kohring et al. ( | )Nationwide ambulatory claims analysis of statutory health-insurance data from physicians in private practice, 2014–2022; girls and women aged ≥10 years, comprising more than 35 million insured persons | Migration background, socioeconomic status and insurance-related differences were not available; transition from paediatric to adult care and symptom onset were not directly observed |\n| Versorgungsatlas Report 24/01 ( | )Nationwide outpatient claims data from statutory ambulatory care, 2012–2022; girls and women aged ≥10 years; 339,718 persons with a documented diagnosis in 2022 | Migration background, socioeconomic status, insurance-related differences and paediatric-to-adult transitions were not assessed; symptom onset and unrecorded care were not observable |\n| Brauer and Geraedts ( | )Mixed-methods study protocol addressing regional healthcare utilisation and quality of care in rural Hesse | No conclusions can be drawn regarding subgroup representation or associations with diagnostic delay |\n| AWMF, ESHRE ( | )Normative clinical guidance; no empirical study population | No empirical assessment of migration background, socioeconomic status, insurance status or paediatric-to-adult transitions |\nStudy populations and assessment of potentially relevant subgroups.\nThe evidence is also insufficient for firm conclusions about adolescents, migration, socioeconomic position, insurance status or transitions between paediatric and adult care. Adolescence deserves separate attention because symptoms may begin before adult services and because parents, schools and care transitions can influence help-seeking and referral. These are priorities for new empirical research, not conclusions that can be quantified from the current evidence base. These areas should be treated as priorities for future research rather than as established explanations of diagnostic delay in Germany.\n5 Implications for German health-services research\nThe literature supports a focused research agenda rather than an unqualified intervention claim. The priorities are closely connected: better measurement is needed to reconstruct the pathway, pathway research must account for regional and sectoral variation, and any proposed improvement should be assessed for equity, acceptability and effectiveness.\n5.1 Standardising diagnostic intervals and integrating complementary data\nThe first priority is methodological. Future studies should prespecify what constitutes symptom onset, first professional contact, clinical suspicion, targeted diagnostic work-up, referral, specialist assessment and the diagnostic endpoint. They should also state whether each interval is patient-reported, prospectively recorded, registry-based or claims-derived, and should report the denominator together with means, medians and appropriate measures of distribution. This level of specification would allow studies to be compared without collapsing distinct intervals into one apparently precise national value.\nStandardisation should be accompanied by deliberate integration of complementary data sources. A prospective longitudinal cohort could record symptoms, help-seeking, consultations, referrals, imaging, procedures, diagnoses, treatment and patient-reported outcomes over time. Linkage with routine-care data, where legally and ethically feasible, could reduce reliance on retrospective recall and reconstruct documented trajectories across sectors. Such linkage would not make claims data a direct measure of symptom onset or clinical reasoning; its value would lie in connecting patient-reported experience with the care that is actually documented.\nStandardisation is also an infrastructural task and not only a matter of study-level reporting. Current German research funding in endometriosis includes dedicated work on harmonising data-collection instruments, database structures and the handling of biosamples across participating sites, with the explicit aim of enabling national and international interoperability. Health-services research would benefit from aligning its interval definitions and pathway variables with these emerging structures at an early stage, so that clinical, biological and utilisation data collected in parallel can later be related to one another instead of remaining in separate repositories.\nA related consideration is that the diagnostic endpoint is a moving target. Work on non-invasive diagnostic approaches, including circulating biomarkers and spectral imaging applied to tissue and to human-relevant in vitro models, is ongoing in German consortia. If such approaches enter routine use, the point at which a diagnosis is regarded as established will shift again. Interval definitions should therefore be specified so that they remain interpretable across changing diagnostic technologies, for example by recording the date of first documented clinical suspicion separately from the date of the confirmatory procedure, whichever procedure that may be.\n5.2 Reconstructing care pathways across sectors and regions\nThe second priority is to study the pathway as an organisational process. Research should examine how primary care, office-based gynaecology, emergency services, radiology, hospitals and specialised centres interact, rather than treating diagnosis as an isolated event. Relevant outcomes include repeated consultations, alternative diagnostic attributions, time to referral, waiting periods, completion of the diagnostic work-up, access to expert imaging and continuity after diagnosis. Claims-based analyses can provide the scale and regional distribution of documented care, while qualitative and mixed-methods designs are needed to explain why pathways diverge.\nReferral-focused research should treat timeliness and diagnostic accuracy as a paired outcome rather than as alternatives. A strategy that accelerates referral while reducing the proportion of referred patients in whom endometriosis is subsequently confirmed shifts the diagnostic burden to specialist centres instead of resolving it; conversely, a highly selective strategy may shorten measured intervals only for patients who would have been recognised in any case. Evaluations should therefore report the positive predictive value of referral alongside interval measures. This requires that patients who are assessed but not referred are documented as well, because restricting verification to referred patients introduces a verification bias under which sensitivity and negative predictive value cannot be estimated.\nRegional analysis should be designed to distinguish variation in documented diagnosis from variation in true symptom-to-diagnosis time. The rural Hesse research programme illustrates the value of combining utilisation data with patient and professional perspectives, but regional effects should not be inferred from a protocol or from claims variation alone. Future studies should therefore prespecify how geography, specialist availability, referral arrangements and local coding or ascertainment practices will be separated analytically.\n5.3 Equity, patient involvement and implementation\nThe third priority is to address populations and outcomes that are currently under-characterised. Dedicated research is needed for adolescents, rural populations and people whose access may be shaped by socioeconomic or migration-related factors, as well as for transitions between paediatric and adult care. Patient organisations should be involved in selecting outcomes, interpreting barriers and judging whether proposed changes are acceptable and meaningful. This is particularly important because a shorter coded interval would not necessarily represent better care if symptoms, trust, shared decision-making or continuity deteriorate.\nFinally, plausible solutions should be evaluated rather than assumed to work. Structured symptom assessment, referral criteria, provider education, expert imaging pathways and coordinated specialist care may all be reasonable targets, but their effects on diagnostic timeliness, symptom burden, quality of life, equity and resource use require empirical testing. Implementation studies should therefore distinguish intervention fidelity from patient benefit and should avoid framing diagnostic delay as a simple deficit of individual awareness or behaviour. Controlled implementation studies addressing structured referral and coordinated specialist care are currently under way in Germany, including a registered trial combining a structured referral strategy with digital patient support (DRKS00038057); results from such studies will be more informative than further descriptive work.\n6 Strengths and limitations\nThis review has four principal strengths. First, it maintains a clear Germany-centred focus. Second, it distinguishes symptom-to-diagnosis intervals from provider, referral and claims-based measures. Third, it combines quantitative, qualitative, routine-data and guideline evidence while preserving the different questions each source can answer. Fourth, it treats the absence of a nationally representative estimate as a substantive finding rather than filling the gap with an inappropriate pooled value.\nThe main limitation is the non-systematic search. The review was based on focused source identification rather than complete exports from all major bibliographic databases, deduplication and independent duplicate screening. Relevant studies may therefore have been missed, and the included evidence may be affected by publication, language and availability bias. The source selection was conducted by the author and was not an independent duplicate process. The underlying studies also have important limitations, including retrospective recall, specialist-centre selection, incomplete separation of Austria and Germany, coding limitations and insufficient data on social and regional inequalities.\nNo formal patient and public involvement process was conducted for this review. The review used published or publicly accessible material and did not collect individual-level participant data; no new ethics approval was therefore sought for the review itself. The absence of patient involvement is a limitation, particularly for an article that interprets patient experience. Future work should involve patient organisations in defining outcomes, interpreting pathway barriers and assessing the acceptability of proposed improvements.\nBecause the search was focused and non-systematic, the review is vulnerable to selection bias, publication bias and incomplete retrieval. These limitations are treated as part of the findings rather than concealed by systematic-review terminology.\nThe review should consequently be read as a transparent critical synthesis and research agenda, not as a definitive estimate of diagnostic delay or a systematic assessment of intervention effectiveness.\n7 Conclusion\nThe German evidence indicates that the route to an endometriosis diagnosis can be prolonged and may involve successive delays in symptom interpretation, clinical recognition, referral and access to specialised care. The available studies do not justify a single nationally representative number because they use different populations, measurement points and diagnostic endpoints.\nThe most useful next step is a German longitudinal health-services study that combines standardised interval definitions, patient-reported experience and outcomes, and documented healthcare trajectories. Until such evidence is available, diagnostic delay should be understood as a cumulative and cross-sector pathway problem. This interpretation is scientifically more defensible than attributing the delay to one actor or presenting heterogeneous estimates as if they were directly comparable.\nStatements\nAuthor contributions\nMW: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review & editing. MS: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review & editing. AK: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review & editing. KH: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review & editing. SL: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review & editing. SM: Writing – original draft, Writing – review & editing. LS: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review & editing.\nFunding\nThe author(s) declared that financial support was not received for this work and/or its publication.\nConflict of interest\nThe author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\nGenerative AI statement\nThe author(s) declared that generative AI was used in the creation of this manuscript. A large language model was used to support idea generation, formulation and manuscript structuring. The author critically reviewed and approved all content, references, interpretations and the final version of the manuscript. The tool was not used as an author and bears no responsibility for the content of the manuscript.\nAny alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.\nPublisher’s note\nAll claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\nReferences\n1.\nBrauerLDe CruppéWGeraedtsM. “Take me seriously”: a qualitative interview study exploring healthcare experiences of endometriosis patients. PLoS One. (2025) 20(5):e0323883. 10.1371/journal.pone.0323883\n2.\nBeckerCMBokorAHeikinheimoOHorneAJansenFKieselLet al. ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Human Reprod Open. (2022) 2022(2):hoac009. 10.1093/hropen/hoac009\n3.\nHudelistGFritzerNThomasANiehuesCOppeltPHaasDet al. Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod. (2012) 27(12):3412–6. 10.1093/humrep/des316\n4.\nBrandesIKleine-BuddeKHeinzeNBinderSKlugCSchippertCet al. Cross-sectional study for derivation of a cut-off value for identification of an early versus delayed diagnosis of endometriosis based on analytical and descriptive research methods. BMC Women’s Health. (2022) 22:521. 10.1186/s12905-022-02044-x\n5.\nKohringCAkmatovMKHolstiegeJBrandesIMechsnerS. The incidence of endometriosis, 2014–2022: an analysis of nationwide claims data from physicians in private practice. Dtsch Arztebl Int. (2024) 121:619–26. 10.3238/arztebl.m2024.0160\n6.\nDe CortePKlinghardtMVon StockumSHeinemannK. Time to diagnose endometriosis: current status, challenges and regional characteristics — a systematic literature review. BJOG. (2025) 132:118–30. 10.1111/1471-0528.17973\n7.\nKohringCHolstiegeJHeuerJDammertzLBrandesIMechsnerSet al. Endometriosis in outpatient care — regional and temporal trends in the period 2012 to 2022. Versorgungsatlas Report No. 24/01. Berlin: Zentralinstitut für die kassenärztliche Versorgung in Deutschland; 2024.10.20364/VA-24.01\n8.\nBrauerLGeraedtsM. Exploring regional healthcare utilisation and quality of care for endometriosis in rural areas in Hesse, Germany: a mixed methods study protocol. BMJ Open. (2023) 13:e074259. 10.1136/bmjopen-2023-074259\n9.\nGerman Society for Gynecology and Obstetrics, Austrian Society for Gynecology and Obstetrics, Swiss Society of Gynecology and Obstetrics. Diagnosis and Therapy of Endometriosis: S2k guideline, AWMF Registry No. 015/045, version April 2025*. AWMF guideline register. Available online at:https://register.awmf.org/de/leitlinien/detail/015-045Accessed 4 September 2026.\n10.\nNational Institute for Health and Care Excellence. Endometriosis: diagnosis and management*. NICE guideline NG73. Published 2017; Accessed 11 November 2024. Available online at:https://www.nice.org.uk/guidance/ng73\n11.\nLiWFengHYeQ. Factors contributing to the delayed diagnosis of endometriosis — a systematic review and meta-analysis. Front Med (Lausanne). (2025) 12:1576490. 10.3389/fmed.2025.1576490\n12.\nFryerJMason-JonesAJWoodwardA. Understanding diagnostic delay for endometriosis: a scoping review using the social-ecological framework. Health Care Women Int. (2025) 46(3):335–51. 10.1080/07399332.2024.2413056\n13.\nSurreyESolimanAMTrenzHBlauer-PetersonCSluisA. Impact of endometriosis diagnostic delays on healthcare resource utilization and costs. Adv Ther. (2020) 37:1087–99. 10.1007/s12325-019-01215-x\n14.\nSimoensSHummelshojLDunselmanGBrandesIDirksenCD’HoogheT. Endometriosis cost assessment (the EndoCost study): a cost-of-illness study protocol. Gynecol Obstet Investig. (2011) 71:170–6. 10.1159/000316055\nSummary\nKeywords\ncare pathway, diagnostic delay, endometriosis, Germany, health-services research, narrative review, patient journey, time to diagnosis\nCitation\nWeiß M, Stope M, Kern AO, Hirsch K, Leonhardt S, Meinhardt S and Schladitz L (2026) Endometriosis care in Germany: a critical narrative review of diagnostic pathways, delays and health services research gaps. Front. Reprod. Health 8:2020975. doi: 10.3389/frph.2026.2020975\nReceived\n07 October 2026\nRevised\n21 October 2026\nAccepted\n26 October 2026\nPublished\n16 November 2026\nVolume\n8 - 2026\nEdited by\nSebastian Ken-Amoah, University of Cape Coast, Ghana\nReviewed by\nJenny King, Picker Institute Europe, United Kingdom\nUpdates\nCopyright\n© 2026 Weiß, Stope, Kern, Hirsch, Leonhardt, Meinhardt and Schladitz.\nThis is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\n*Correspondence: Scott Meinhardt scott.meinhardt@whz.de\nDisclaimer\nAll claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.","source_license":"CC0","license_restricted":false}